PDS Biotechnology Corp Payments of Debt Issuance Costs
PDS Biotechnology Corp (PDSB) reported Payments of Debt Issuance Costs of $449.33 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2025-03-27
- PDS Biotechnology Corp payments of debt issuance costs for the quarter ending 2023-12-31 was $449.33K.
- PDS Biotechnology Corp payments of debt issuance costs for the quarter ending 2023-09-30 was -$449.33K.
- PDS Biotechnology Corp payments of debt issuance costs for the quarter ending 2023-06-30 was $0.00.
- PDS Biotechnology Corp payments of debt issuance costs for the quarter ending 2023-03-31 was $449.33K.
- PDS Biotechnology Corp payments of debt issuance costs for fiscal 2023 was $449.33K, a 0.00% change from fiscal 2022.
- PDS Biotechnology Corp payments of debt issuance costs for fiscal 2022 was $449.33K.
- PDS Biotechnology Corp payments of debt issuance costs for fiscal 2021 was $0.00.
- PDS Biotechnology Corp payments of debt issuance costs for fiscal 2018 was $990.00K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month | Payments of Debt Issuance Costs 12 month as first filed |
|---|---|---|---|---|---|
| 2023-12-31 | $449.33K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $0.00 derived: sum of 2 quarters · filed 2025-03-27 | $0.00 derived: sum of 3 quarters · filed 2025-03-27 | $449.33K 10-K · filed 2025-03-27 | $0.00 10-K · filed 2024-03-28 |
| 2023-09-30 | -$449.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$449.33K derived: sum of 2 quarters · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | $0.00 derived: sum of 4 quarters · filed 2024-03-28 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $449.33K 10-Q · filed 2023-08-14 | $449.33K derived: sum of 3 quarters · filed 2024-03-28 | ||
| 2023-03-31 | $449.33K 10-Q · filed 2023-05-15 | $449.33K derived: sum of 2 quarters · filed 2024-03-28 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $449.33K 10-K · filed 2024-03-28 | |||
| 2022-09-30 | $449.33K 10-Q · filed 2024-11-14 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $0.00 10-K · filed 2023-03-28 | |||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $0.00 derived: sum of 2 quarters · filed 2019-02-21 | $900.00K derived: sum of 3 quarters · filed 2019-02-21 | $990.00K 10-K · filed 2019-02-21 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $900.00K derived: sum of 2 quarters · filed 2018-11-01 | $990.00K 10-Q · filed 2018-11-01 | $990.00K derived: sum of 4 quarters · filed 2019-02-21 | |
| 2018-06-30 | $900.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $990.00K 10-Q · filed 2018-08-01 | $990.00K derived: sum of 3 quarters · filed 2019-02-21 | $990.00K derived: sum of 4 quarters · filed 2019-02-21 | |
| 2018-03-31 | $90.00K 10-Q · filed 2018-05-01 | $90.00K derived: sum of 2 quarters · filed 2019-02-21 | $90.00K derived: sum of 3 quarters · filed 2019-02-21 | $90.00K derived: sum of 4 quarters · filed 2019-02-21 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $0.00 derived: sum of 2 quarters · filed 2019-02-21 | $0.00 derived: sum of 3 quarters · filed 2019-02-21 | $0.00 10-K · filed 2019-02-21 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $0.00 derived: sum of 2 quarters · filed 2018-11-01 | $0.00 10-Q · filed 2018-11-01 | $0.00 derived: sum of 4 quarters · filed 2018-11-01 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $0.00 10-Q · filed 2018-08-01 | $0.00 derived: sum of 3 quarters · filed 2018-08-01 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-01 | $0.00 derived: sum of 2 quarters · filed 2018-05-01 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $219.04K 10-K · filed 2018-03-01 | |||
| 2016-09-30 | $219.04K 10-Q · filed 2017-11-01 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $0.00 10-K · filed 2018-03-01 | |||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-01 | ||||
| 2014-12-31 | -$64.14K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $95.00K 10-K · filed 2017-03-02 | |||
| 2014-09-30 | $159.14K 10-Q · filed 2015-11-06 | ||||
| 2013-12-31 | $0.00 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |